Teladoc, Inc. (NYSE:TDOC) CFO Mark Hirschhorn sold 25,000 shares of Teladoc stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $32.37, for a total transaction of $809,250.00. Following the transaction, the chief financial officer now owns 20,887 shares of the company’s stock, valued at approximately $676,112.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Mark Hirschhorn also recently made the following trade(s):
- On Tuesday, October 17th, Mark Hirschhorn sold 35,000 shares of Teladoc stock. The stock was sold at an average price of $32.84, for a total transaction of $1,149,400.00.
- On Monday, October 2nd, Mark Hirschhorn sold 10,000 shares of Teladoc stock. The stock was sold at an average price of $34.04, for a total transaction of $340,400.00.
- On Friday, September 22nd, Mark Hirschhorn sold 25,000 shares of Teladoc stock. The stock was sold at an average price of $31.93, for a total transaction of $798,250.00.
Shares of Teladoc, Inc. (NYSE TDOC) traded up 3.94% during mid-day trading on Friday, hitting $33.00. 801,974 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $33.27 and a 200-day moving average price of $33.27. Teladoc, Inc. has a 52 week low of $14.00 and a 52 week high of $37.55. The company’s market capitalization is $1.87 billion.
Teladoc (NYSE:TDOC) last released its earnings results on Wednesday, August 2nd. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.02). Teladoc had a negative return on equity of 19.88% and a negative net margin of 47.75%. The business had revenue of $44.60 million for the quarter, compared to analyst estimates of $44.39 million. During the same period in the prior year, the business earned ($0.38) EPS. The company’s revenue for the quarter was up 68.3% on a year-over-year basis. On average, equities analysts anticipate that Teladoc, Inc. will post ($1.46) EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Mark Hirschhorn Sells 25,000 Shares of Teladoc, Inc. (TDOC) Stock” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/10/27/insider-selling-teladoc-inc-tdoc-cfo-sells-25000-shares-of-stock.html.
A number of equities research analysts have recently commented on TDOC shares. Piper Jaffray Companies restated a “buy” rating and issued a $42.00 target price on shares of Teladoc in a report on Friday, July 28th. BidaskClub downgraded shares of Teladoc from a “hold” rating to a “sell” rating in a research note on Thursday, August 3rd. Zacks Investment Research downgraded shares of Teladoc from a “buy” rating to a “hold” rating in a research note on Wednesday, October 18th. Cantor Fitzgerald reiterated a “hold” rating on shares of Teladoc in a research note on Monday, August 28th. Finally, KeyCorp reiterated a “buy” rating and set a $37.00 price objective on shares of Teladoc in a research note on Sunday, September 17th. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Teladoc presently has a consensus rating of “Buy” and an average target price of $38.00.
A number of institutional investors have recently made changes to their positions in TDOC. Russell Investments Group Ltd. bought a new position in shares of Teladoc in the first quarter valued at approximately $583,000. Great West Life Assurance Co. Can bought a new position in shares of Teladoc in the first quarter valued at approximately $105,000. US Bancorp DE lifted its holdings in shares of Teladoc by 10.3% in the first quarter. US Bancorp DE now owns 4,617 shares of the health services provider’s stock valued at $116,000 after purchasing an additional 433 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Teladoc by 115.3% during the first quarter. Bank of New York Mellon Corp now owns 227,360 shares of the health services provider’s stock worth $5,683,000 after acquiring an additional 121,736 shares during the period. Finally, Swiss National Bank lifted its holdings in Teladoc by 37.5% during the first quarter. Swiss National Bank now owns 56,800 shares of the health services provider’s stock worth $1,420,000 after acquiring an additional 15,500 shares during the period.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.